Switch theme
Sign up to access all valuation multiples
Blue Moon has a portfolio of market-leading products in three categories: fabric care, personal hygiene, and home care. Fabric care comprises around 90% of the group’s revenue. As a pioneer in China’s household care market, it holds a leading market share by value in China’s liquid laundry detergent and liquid soap markets, as at 2024. Blue Moon is also an early entrant into e-commerce, with the online channel contributing nearly 60% of 2024 sales. Most of Blue Moon’s core products are marketed under the namesake brand.
2007
7.4K+
LTM Revenue $1.1B
LTM EBITDA -$30.0M
$2.3B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Blue Moon Group has a last 12-month revenue (LTM) of $1.1B and a last 12-month EBITDA of -$30.0M.
In the most recent fiscal year, Blue Moon Group achieved revenue of $1.1B and an EBITDA of -$69.6M.
Blue Moon Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Blue Moon Group valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | XXX | $1.1B | XXX | XXX | XXX |
| Gross Profit | $689M | XXX | $662M | XXX | XXX | XXX |
| Gross Margin | 61% | XXX | 61% | XXX | XXX | XXX |
| EBITDA | -$30.0M | XXX | -$69.6M | XXX | XXX | XXX |
| EBITDA Margin | -3% | XXX | -6% | XXX | XXX | XXX |
| EBIT | -$51.4M | XXX | -$120M | XXX | XXX | XXX |
| EBIT Margin | -5% | XXX | -11% | XXX | XXX | XXX |
| Net Profit | -$40.1M | XXX | -$95.6M | XXX | XXX | XXX |
| Net Margin | -4% | XXX | -9% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Blue Moon Group's stock price is HKD 4 (or $1).
Blue Moon Group has current market cap of HKD 23.5B (or $3.0B), and EV of HKD 18.3B (or $2.3B).
See Blue Moon Group trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.3B | $3.0B | XXX | XXX | XXX | XXX | $-0.01 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Blue Moon Group has market cap of $3.0B and EV of $2.3B.
Blue Moon Group's trades at 2.1x EV/Revenue multiple, and -33.6x EV/EBITDA.
Equity research analysts estimate Blue Moon Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Blue Moon Group has a P/E ratio of -74.8x.
See valuation multiples for Blue Moon Group and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $3.0B | XXX | $3.0B | XXX | XXX | XXX |
| EV (current) | $2.3B | XXX | $2.3B | XXX | XXX | XXX |
| EV/Revenue | 2.1x | XXX | 2.1x | XXX | XXX | XXX |
| EV/EBITDA | -78.1x | XXX | -33.6x | XXX | XXX | XXX |
| EV/EBIT | -45.5x | XXX | -19.5x | XXX | XXX | XXX |
| EV/Gross Profit | 3.4x | XXX | n/a | XXX | XXX | XXX |
| P/E | -74.8x | XXX | -31.4x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -17.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialBlue Moon Group's last 12 month revenue growth is 9%
Blue Moon Group's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Blue Moon Group's rule of 40 is 18% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Blue Moon Group's rule of X is 20% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Blue Moon Group and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 9% | XXX | 9% | XXX | XXX | XXX |
| EBITDA Margin | -3% | XXX | -6% | XXX | XXX | XXX |
| EBITDA Growth | -264% | XXX | -30% | XXX | XXX | XXX |
| Rule of 40 | 18% | XXX | 3% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 20% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 59% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 72% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
| EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
| Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Blue Moon Group acquired XXX companies to date.
Last acquisition by Blue Moon Group was XXXXXXXX, XXXXX XXXXX XXXXXX . Blue Moon Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Blue Moon Group founded? | Blue Moon Group was founded in 2007. |
| Where is Blue Moon Group headquartered? | Blue Moon Group is headquartered in Hong Kong. |
| How many employees does Blue Moon Group have? | As of today, Blue Moon Group has 7.4K+ employees. |
| Who is the CEO of Blue Moon Group? | Blue Moon Group's CEO is Mr. Qiuping Luo. |
| Is Blue Moon Group publicy listed? | Yes, Blue Moon Group is a public company listed on HKG. |
| What is the stock symbol of Blue Moon Group? | Blue Moon Group trades under 06993 ticker. |
| When did Blue Moon Group go public? | Blue Moon Group went public in 2020. |
| Who are competitors of Blue Moon Group? | Similar companies to Blue Moon Group include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm. |
| What is the current market cap of Blue Moon Group? | Blue Moon Group's current market cap is $3.0B |
| What is the current revenue of Blue Moon Group? | Blue Moon Group's last 12 months revenue is $1.1B. |
| What is the current revenue growth of Blue Moon Group? | Blue Moon Group revenue growth (NTM/LTM) is 9%. |
| What is the current EV/Revenue multiple of Blue Moon Group? | Current revenue multiple of Blue Moon Group is 2.1x. |
| Is Blue Moon Group profitable? | Yes, Blue Moon Group is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Blue Moon Group? | Blue Moon Group's last 12 months EBITDA is -$30.0M. |
| What is Blue Moon Group's EBITDA margin? | Blue Moon Group's last 12 months EBITDA margin is -3%. |
| What is the current EV/EBITDA multiple of Blue Moon Group? | Current EBITDA multiple of Blue Moon Group is -78.1x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
